Levy P Y, Drancourt M, Etienne J, Auvergnat J C, Beytout J, Sainty J M, Goldstein F, Raoult D
Centre National de Référence des Rickettsioses, Centre Hospitalier Universitaire la Timone, Marseille, France.
Antimicrob Agents Chemother. 1991 Mar;35(3):533-7. doi: 10.1128/AAC.35.3.533.
We studied 32 cases of Q fever endocarditis diagnosed in France between January 1985 and December 1989 to evaluate the efficacies of the different regimens of antibiotics used for treatment. Each patient was monitored during the treatment (range, 12 to 60 months), and clinical and biological information was computerized. Various treatments were prescribed, including doxycycline alone (9 cases) or in association with rifampin (4 cases), quinolones (16 cases), or sulfamethoxazole-trimethoprim (1 case). Two patients died before the beginning of the treatment. Nineteen patients had hemodynamic failure and subsequently underwent valve replacement. Nine valve tissue cultures were positive despite previous antibiotic treatment. In terms of their effects on mortality, the difference between doxycycline alone and doxycycline plus quinolones is statistically significant. We conclude that the addition of quinolones to doxycycline is beneficial. On the basis of clinical, serological, and valve tissue culture results, no treatment was able to cure Q fever endocarditis within 2 years, even with a combination of antibiotics. We advise a minimum duration of treatment of 3 years with therapy combining quinolones and doxycycline.
我们研究了1985年1月至1989年12月期间在法国诊断出的32例Q热心内膜炎病例,以评估用于治疗的不同抗生素方案的疗效。在治疗期间(范围为12至60个月)对每位患者进行监测,并将临床和生物学信息进行计算机化处理。采用了各种治疗方法,包括单独使用强力霉素(9例)或与利福平(4例)、喹诺酮类(16例)或磺胺甲恶唑-甲氧苄啶(1例)联合使用。两名患者在治疗开始前死亡。19例患者出现血流动力学衰竭,随后接受了瓣膜置换术。尽管先前进行了抗生素治疗,但9份瓣膜组织培养结果呈阳性。就其对死亡率的影响而言,单独使用强力霉素与强力霉素加喹诺酮类之间的差异具有统计学意义。我们得出结论,在强力霉素中添加喹诺酮类是有益的。根据临床、血清学和瓣膜组织培养结果,即使联合使用抗生素,也没有任何治疗方法能够在2年内治愈Q热心内膜炎。我们建议使用喹诺酮类和强力霉素联合治疗的最短疗程为3年。